Startup Funding News

Integral combines AI-assisted accounting, tax and payroll operations with licensed professionals for small and mid-sized businesses in Germany. Its platform connects bank transactions, receipts, invoices and payroll data, automates recurring work and keeps experts responsible for review and advice.

Apex Intelligence is developing self-evolving foundation models to help researchers generate and test scientific hypotheses.

A clinical-stage biotechnology company developing an oral drug candidate for thyroid eye disease.

Quartz brings personal savings and investment accounts into one view and uses an AI assistant to help customers understand their portfolios.

Expertise AI lets businesses deploy AI agents for sales, customer support and internal workflows. Teams connect business knowledge and tools, select or configure agent workflows, then use custom or prebuilt agents to qualify leads, answer customer questions, book meetings and update systems; enterprise plans add dedicated infrastructure and deployment support.

Axo Longevity is a preventive-health membership that combines recurring laboratory testing with personalised insights and an AI health coach.

A semiconductor company developing custom three-dimensional SRAM memory to increase bandwidth and capacity for AI computing chips.

CADDi’s AI data platform structures and connects the drawings, specifications, procurement records and other fragmented information used across manufacturing. Products such as CADDi Drawer and CADDi Quote help engineering, procurement and production teams find reusable design knowledge, manage quoting and turn operational decisions into searchable company data; the platform serves manufacturers internationally.

Nix Biosensors makes a wearable sweat sensor and companion apps that continuously measure fluid and electrolyte loss during activity. Its algorithms turn sweat readings into personalized hydration guidance for individual athletes and dashboards for coaches, teams, military, labor and research groups; the consumer biosensor is available while Nix Health is in beta.

Circle Pharma discovers macrocycle medicines for cancer and other serious diseases using its MXMO platform, which combines computational, structure-based design with synthetic chemistry to create cell-permeable compounds against difficult protein targets. Its lead programs are investigational and at discovery or preclinical stages.